Sawai Group Holdings, a pharmaceutical company headquartered in Osaka, will take over all factories and some employees from Kobayashi Kako, which was found to have mixed sleep-inducing agents in therapeutic agents such as athlete's foot. It was revealed that they had agreed.
Kobayashi Kako, a pharmaceutical manufacturer in Awara City, Fukui Prefecture, discovered last year that a sleep-inducing agent was mixed in a drug for treating fungal diseases such as athlete's foot that was manufactured and sold. I was being punished.
Under these circumstances, Sawai Group Holdings, which is headquartered in Osaka City, has agreed to take over all factories, R & D facilities, and up to 500 employees from Kobayashi Kako to a new company established by Sawai. However, we are planning to complete the procedure at the end of March next year.
The transfer amount has not been disclosed.
Sawai plans to start shipping from the factory it took over in April next year.
Mitsuo Sawai, Chairman of Sawai Group Holdings, said at a press conference held in Osaka City on the afternoon of the 3rd, "In the generic drug industry, ensuring quality and strengthening supply capacity are urgent issues. I want to build trust and trust from scratch under the company. "